A metabolic state in the cancer-associated fibroblast differentiation continuum of colorectal cancer
Frontiers in Cell and Developmental Biology · 06.11.2026 · 14
DOI: 10.3389/fcell.2026.1994563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 06.11.2026. Verfasst von Jiajie Zhou. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The metabolic heterogeneity of cancer-associated fibroblasts (CAFs) in the colorectal cancer (CRC) microenvironment remains poorly understood.
Methods
We profiled 86,142 cells from two independent CRC cohorts (GSE132465, GSE144735) using single-cell RNA-sequencing and validated findings in a public Visium dataset (GSE285505, 3,493 spots) and an external spatial cohort (GSE267401, 4 sections). Unsupervised clustering identified CAF subtypes, regulon analysis (SCENIC) mapped transcriptional drivers, and spatial deconvolution (cell2location) localized CAF populations in tissue.
Findings
Unsupervised clustering of 13,003 CAFs identified a metabolically distinct subpopulation (meCAF, 4.1% of CAFs) that scored highest for glycolysis (Δ = +0.60, P < 1e-4), lactate metabolism (Δ = +0.46, P < 1e-4) and hypoxia among nine metabolic pathways compared across all three CAF subtypes. SCENIC analysis inferred HIF1A as the regulon with the highest meCAF specificity (ΔAUC = +0.111, 95% CI 0.081 to 0.134, P = 2.4e-07 by patient-paired Wilcoxon test, 23/23 patients concordant). Spatial profiling confirmed meCAF enrichment at the tumor-stroma interface with spatial concordance with lactate metabolism (Spearman ρ = 0.29–0.75). meCAF abundance was inversely correlated with distance to the cancer epithelium (ρ = −0.317, p < 3e-82), accompanied by a metabolic activity gradient. In TCGA-COADREAD (n = 410), the meCAF signature varied significantly across consensus molecular subtypes (ANOVA p = 1.9e-18), with the highest scores in CMS1 (immune subtype) and the lowest in CMS2 (epithelial subtype).
Interpretation
These findings reveal a metabolically distinct CAF subpopulation operating within spatially restricted periepithelial micro-niches, with its clinical association to the immune-rich CMS1 subtype suggesting that stromal metabolic state may relate to the immune context of CRC.
Zitieren
APA
Zhou, J. (2026). A metabolic state in the cancer-associated fibroblast differentiation continuum of colorectal cancer. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1994563
Vancouver
Zhou J. A metabolic state in the cancer-associated fibroblast differentiation continuum of colorectal cancer. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1994563
BibTeX
@article{Zhou2026,
author = {Zhou, Jiajie},
title = {A metabolic state in the cancer-associated fibroblast differentiation continuum of colorectal cancer},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1994563}
}
EUVIMED